In this episode of Stuff You Should Know, the hosts explore the unusual medical conditions that can turn human skin blue. The discussion centers on the Fugate family of Kentucky, whose members displayed striking blue skin due to methemoglobinemia—a rare genetic condition affecting blood's oxygen-carrying capacity. Through generations of isolation and inbreeding in their small community, the gene perpetuated until modern medicine offered a simple treatment that some family members chose to refuse.
The episode also examines argyria, a condition caused by excessive silver consumption that permanently discolors skin, and discusses the case of Paul Karason, who turned blue from drinking homemade colloidal silver. Beyond these medical curiosities, the hosts address broader questions about human skin pigmentation, explaining how melanin production can adapt to environmental conditions in as few as 100 generations and what this reveals about the biological basis—or lack thereof—of racial categories.

Sign up for Shortform to access the whole episode summary along with additional materials like counterarguments and context.
Martin Fugate, a French immigrant, arrived in Kentucky in 1820 and married Elizabeth Smith, settling near Troublesome Creek in Hazard County. Unknown to both, they each carried a rare recessive gene for methemoglobinemia, which interferes with blood's oxygen-carrying capacity and causes dramatically blue-tinted skin. Four of their seven children were born with unmistakably blue skin. The stigma and curiosity surrounding their appearance led the family to further isolate themselves, resulting in generations of cousin marriages and inbreeding that perpetuated the blue-skinned trait.
A doctor noted that the likelihood of two unrelated carriers meeting was about one in 100,000. However, in the isolated community, repeated inbreeding dropped this risk dramatically to one in eight when both parents carried the gene. Martin himself had only slight blue coloring, while Elizabeth was a symptomless carrier. The full manifestation appeared only when both copies of the gene came together in their children.
As generations passed and descendants mixed with people outside the isolated community, the frequency of blue births naturally decreased. By 2012, only a few blue Fugates remained. Modern medicine provided an easy solution: a daily methylene blue pill could reverse the blue skin by treating the underlying blood abnormality. However, it's believed that at least one Fugate chose to retain their blue coloring as a point of pride in their unique family history.
In the Fugate family's case, skin color changes resulted from a blood disorder, not pigmentation. The typical pinkish hue of Caucasian skin comes from minimal melanin and blood color showing through translucent tissues. Blood is red due to hemoglobin, a protein containing iron that binds oxygen. The body naturally produces some methemoglobin during regular metabolism—a structurally similar protein with oxidized iron that cannot bind oxygen. An enzyme called reduced nicotinamide adenine dinucleotide cytochrome B5 reductase converts methemoglobin back to functional hemoglobin, keeping methemoglobin levels very low in healthy individuals.
Some individuals inherit a deficiency in the enzyme responsible for reversing methemoglobin back to hemoglobin. When methemoglobin reaches about 1% of total blood globins, blue skin appears. This threshold is remarkably low—99% of blood globins may still be functioning hemoglobin, but as little as 1% methemoglobin produces a visible blue tint. Despite the pronounced blue color, people with this condition often maintain adequate oxygen transport and may experience only mild symptoms.
Elizabeth Smith-Fugate's almost translucent, very pale skin likely contributed to her children's exceptionally dark blue appearance. The lack of melanin provided little barrier to the visual impact of blue-tinged blood beneath the skin, creating the "ultimate recipe for blueness" observed in the Fugate descendants.
Argyria is a disorder marked by bluish or silvery skin resulting from prolonged silver ion accumulation. When silver exposure exceeds the body's ability to eliminate it—especially from regularly ingesting colloidal silver—ions build up in tissues. When skin with accumulated silver is exposed to light, the silver ions form dark deposits producing a silverish or bluish-gray discoloration. Unlike methemoglobinemia, argyria is irreversible with no effective treatment to remove silver deposits from tissues.
Paul Karason became one of the most prominent examples of argyria after consuming about ten ounces of homemade colloidal silver daily and rubbing it on his face. His persistent use quickly overwhelmed his body's natural ability to remove the metal, turning his skin, mucous membranes, and gums a deep blue. Despite becoming a cautionary tale, Karason continued his regimen until his death in 2013 from heart attack and stroke, rather than silver toxicity itself.
Silver's longstanding association with medicine contributes to misconceptions about its safety. Historically, silver compounds were used as early antimicrobials before modern antibiotics. However, silver was phased out as internal medicine due to inefficacy at safe doses and the risk of turning users blue. In 1999, the FDA reclassified silver from medicine to dietary supplement due to lack of peer-reviewed scientific evidence. Despite this, various public figures have promoted colloidal silver, though there is no credible scientific support for consuming it.
Widespread colloidal silver use presents a broader public health concern. Silver's antimicrobial properties make it a last-resort agent for treating antibiotic-resistant infections like MRSA. However, consuming colloidal silver fosters the development of silver-resistant bacteria, threatening to undermine silver's effectiveness in medicine and society's ability to combat infections that resist traditional antibiotics.
Dr. Madison Cawein, a hematologist at the University of Kentucky, became determined to understand and treat the blue-skinned people's condition. After initial attempts to chase down affected individuals failed, he moved to Hazard County and started asking at local clinics. His persistence paid off when a nurse provided a lead that eventually connected him with the blue-skinned Ritchie siblings.
Dr. Cawein identified that the blue skin was caused by methemoglobinemia and found that methylene blue could boost the cytochrome B5 reductase enzyme function, helping convert methemoglobin back into hemoglobin. When he injected the Ritchie children with methylene blue, their skin color returned to normal within minutes, bringing overwhelming relief to the family.
Initial treatment required methylene blue injections, but advances later allowed for convenient oral pill forms. Today, those with hereditary methemoglobinemia can take a daily tablet to maintain normal skin tone. However, as the stigma faded and treatment became optional, some family members have chosen to embrace their distinctive heritage by remaining blue, reflecting a shift from embarrassment to a celebration of identity and history.
Recent research reveals how rapidly human skin color can change in response to environmental factors, challenging traditional views of race and highlighting human adaptability.
Scientific findings show that shifts in human skin pigmentation can occur in as few as 100 generations, or about 2,000 years—extremely quick in evolutionary terms. Chuck Bryant explains that melanin production changes according to UV exposure in new environments, causing darker or lighter skin over generations. Josh Clark notes that skin color is not fixed but is determined by the amount of melanin our genes instruct our bodies to produce, directly triggered by local UV exposure.
Adaptation of skin pigmentation is a balancing act between UV protection and vitamin D production. In regions with intense sunlight, darker skin with more melanin provides natural protection against skin cancer and reproductive problems. In areas with less sunlight, lighter skin is favored as it allows better vitamin D synthesis. Clark explains that our bodies naturally adjust melanin production according to local UV conditions for optimal health.
The quick pace of pigmentation change proves that racial categories are not biologically fixed but rather social constructs. Melanin production responds directly to environmental exposure, not to any intrinsic human categories. Clark underlines that anyone's lineage likely includes both light-skinned and dark-skinned ancestors, underscoring the meaninglessness of racial categorization, as ancestry and skin tone have always been subject to change with migration and local adaptation.
1-Page Summary
Martin Fugate, a French immigrant and orphan, arrived in Kentucky in 1820. With little knowledge about his family's health history, he married Elizabeth Smith, a pale-skinned redheaded American. The couple settled near Troublesome Creek in Hazard County, Kentucky, establishing a homestead in an already isolated part of Appalachia. Unbeknownst to both, they each carried a rare recessive genetic mutation that causes methemoglobinemia.
This genetic condition interferes with the blood's ability to carry oxygen, resulting in dramatically blue-tinted skin. When Martin and Elizabeth had children, four out of their seven offspring were born with dark blue skin—not merely a bluish hue but unmistakably blue pigmentation. The rarity of both parents carrying this specific gene made their story extraordinary.
As the Fugate family became known as the "blue family," the stigma and curiosity surrounding their appearance led them to further seclude themselves. Over generations, this isolation resulted in cousin marriages and inbreeding within the community. Their descendants intermarried with blood relatives and neighboring families who were also tied to the Fugate line, perpetuating the blue-skinned trait in the region.
The presence of methemoglobinemia in the Fugate family is remarkable due to the exceedingly low odds of two unrelated carriers meeting. A doctor cited in contemporary reports stated the likelihood was about one in 100,000. However, in the rural isolation of 19th-century Kentucky, repeated inbreeding dropped this risk dramatically, down to one in eight when both parents carried the gene. This significantly heightened the odds of producing more blue-skinned children in each generation.
Martin Fugate himself was thought to have only slight blue coloring, while his wife Elizabeth was a symptomless carrier. The full manifestation of the trait only appeared in their children when both copies of the gene came together, leading to striking cases of dark blue skin.
Methemoglobinemia and the Blue Fugate Family
Skin color changes are often associated with melanin, but in the case of the blue-skinned Fugate family, the cause is a blood disorder, not pigmentation. The typical pinkish hue of Caucasian skin comes from minimal melanin and the color of blood shining through translucent tissues.
Blood is red due to hemoglobin, a protein in red blood cells. Hemoglobin contains a heme group with an iron atom at its core, which binds with oxygen, enabling oxygen transport throughout the body. The red color comes from the iron in a specific oxidation state capable of this crucial function. The idea that blood is blue inside the body until it is exposed to air is a playground myth; in reality, blood is always red because of the iron-oxygen interaction in hemoglobin.
The body naturally produces some methemoglobin during regular metabolism. Methemoglobin is structurally similar to hemoglobin but contains oxidized iron—a ferric instead of a ferrous ion. This oxidized iron cannot bind oxygen, rendering methemoglobin useless for transporting oxygen.
Most people have an enzyme called reduced nicotinamide adenine dinucleotide cytochrome B5 reductase. This enzyme converts methemoglobin’s ferric iron back into the ferrous state, transforming it into functional hemoglobin. As a result, methemoglobin levels remain very low in healthy individuals, and oxygenation is not impaired.
Some individuals inherit a deficiency in the enzyme responsible for reversing methemoglobin back to hemoglobin. In these cases, known as methemoglobinemia, methemoglobin accumulates in the blood.
Even a small buildup of methemoglobin—when it reaches about 1% of total blood globins—can cause blue skin. This threshold is very low: 99% of blood globins may still be functioning hemoglobin, but as little as 1% methemoglobin produces a visible blue tint.
The blue coloration is not a skin condition but a result of light interacting with elevated methemoglobin levels in the blood. Since methemoglobin cannot carry oxygen, it gives blood a blue hue that, when ...
The Biochemistry of Skin Color
Argyria is a disorder marked by bluish or silvery skin, and it results from the prolonged accumulation of silver ions in the body. Normally, small amounts of silver can be excreted safely through urine and feces. However, when silver exposure exceeds the body’s ability to eliminate it—especially by regularly ingesting or applying colloidal silver—these ions begin to build up in tissues.
When skin with accumulated silver is exposed to light, the silver ions react and form dark deposits in the skin, producing a silverish or bluish-gray discoloration. This effect can color not only the skin but also mucous membranes, the gums, and the interior of the mouth and nose.
A key danger of argyria is its permanence. There is no effective treatment or pill to remove the silver deposits from the tissues. Unlike methemoglobinemia, where therapies can restore normal blood function, argyria's discoloration is irreversible and lifelong.
Paul Karasan, known as “Papa Smurf,” became one of the most prominent examples of argyria after images of his striking blue skin circulated widely online. Karasan began consuming about ten ounces of homemade colloidal silver daily and also rubbed it onto his face. He drew inspiration from reports of silver ions rejuvenating cut flowers and hypothesized it could have powerful effects on the human body.
His persistent use of colloidal silver quickly overwhelmed his body’s natural ability to remove the metal, resulting in a dramatic transformation—his skin, mucous membranes, gums, and the inside of his mouth turned a deep blue, making him entirely blue in appearance. Despite becoming a cautionary tale about colloidal silver, Karasan continued his regimen until his death in 2013, which was attributed to a heart attack and a smoking-related stroke rather than to silver toxicity itself.
Other notable cases include Stan Jones, a Montana politician who ingested colloidal silver in preparation for antibiotic shortages, and Rosemary Jacobs, who developed argyria after receiving silver-containing nasal drops as a child.
Silver’s longstanding association with medicine contributes to misconceptions about its safety in supplements. Historically, silver nitrate was used by figures like Pliny the Elder and Cyrus the Great, and by monks in the Middle Ages, as a treatment for ulcers and burns. Before modern antibiotics, diluted silver compounds were used as early antimicrobials.
Silver was also used internally: for example, silver eye drops were routinely administered to newborns unt ...
Argyria and Colloidal Silver Toxicity
Dr. Madison Cawein, a hematologist at the University of Kentucky, heard about the mysterious blue-skinned people and became determined to understand and treat their condition. Driven by curiosity, he became obsessed with finding affected individuals and learning what caused their distinctive appearance. Cawein spent time searching for blue family members by waiting in the woods near their homes, even attempting to chase them down when he saw them, though they often fled out of self-consciousness. Realizing a different approach was needed, he moved to Hazard County near Troublesome Creek and started asking around at local clinics, inquiring whether anyone had ever treated a blue-skinned patient.
His persistence paid off when a nurse at a local clinic provided a key lead. She recalled treating a self-conscious blue-skinned woman who came discreetly to the back door of the clinic. This encounter eventually led Cawein to the Ritchie siblings, a blue-skinned family who had lived in significant isolation because of their unusual coloring.
Dr. Cawein’s research identified that the blue skin was caused by methemoglobinemia, a blood disorder where excess methemoglobin is present in relation to hemoglobin, impairing oxygen delivery throughout the body. He found that methylene blue, already in medical use for tissue staining and malaria treatment, could offer a solution. The compound works by boosting the function of the cytochrome B5 reductase enzyme, helping it convert methemoglobin back into hemoglobin.
Putting his theory to the test, Cawein injected the Ritchie children with methylene blue. The result was immediate: within minutes, their skin color returned to normal. This transformation brought overwhelming relief and joy to the family, who had endured a lifetime of isolation and self-consciousness because of their ...
Medical Breakthrough in Treatment
Recent research reveals how rapidly human skin color can change in response to environmental factors, challenging traditional views of race and highlighting the adaptability of the human body.
Scientific findings show that shifts in human skin pigmentation can occur in as few as 100 generations, or about 2,000 years. While this may sound lengthy, it is extremely quick in the context of human evolution. Populations that migrate between regions with different levels of ultraviolet (UV) radiation—such as moving from areas near the equator to regions with low sunlight, or vice versa—begin to adapt. As Chuck Bryant explains, melanin production changes according to the UV exposure in the new environment, causing darker or lighter skin over generations.
Josh Clark notes that skin color is not a fixed trait but is instead determined by the amount of melanin our genes instruct our bodies to produce. This melanin production is directly triggered by the local UV exposure a population experiences, meaning that skin color will change to support survival in new conditions.
Adaptation of skin pigmentation is a balancing act determined by the body’s need for UV protection and vitamin D production. In regions with intense sunlight, excessive UV exposure can increase skin cancer risk and cause reproductive problems, which promotes the evolution of darker skin with more melanin to provide natural protection. Conversely, in areas with less sunlight, low UV exposure can impair vitamin D production, leading to weaker bones, so lighter skin is favored as it allows more UV penetration and better synthesis of vitamin D.
Josh Clark explains that our bodies naturally adjust melanin production according to local UV conditions, increasing or decreasing pigmentation as ...
Human Genetic Adaptation and Skin Pigmentation
Download the Shortform Chrome extension for your browser
